Select Your Region
Americas
Europe
Africa
Global
Find participating medical centers and current study status in each of them
Find participating medical centers
-
Home
-
Clinical Study Finder
- CLL14
A clinical study to compare obinutuzumab in combination with venetoclax and obinutuzumab in combination with chlorambucil in people with previously untreated chronic lymphocytic leukaemia who have other medical conditions
A Study to Compare the Efficacy and Safety of Obinutuzumab + Venetoclax (GDC-0199) Versus Obinutuzumab + Chlorambucil in Participants With Chronic Lymphocytic Leukemia
-
Cancer -
Leukemia -
Chronic Lymphocytic Leukemia
- Results
-
Download -
Study results
LPS BO25323 CLL14 Interim Results March 2020 Bulgarian
(PDF, 0.4 MB)
LPS BO25323 CLL14 Interim Results March 2020 Danish
(PDF, 0.4 MB)
LPS BO25323 CLL14 Interim Results March 2020 English
(PDF, 1.6 MB)
LPS BO25323 CLL14 Interim Results March 2020 Estonia Estonian
(PDF, 0.3 MB)
LPS BO25323 CLL14 Interim Results March 2020 Canada French
(PDF, 0.5 MB)
LPS BO25323 CLL14 Interim Results March 2020 France French
(PDF, 0.4 MB)
LPS BO25323 CLL14 Interim Results March 2020 Switzerland French
(PDF, 0.4 MB)
LPS BO25323 CLL14 Interim Results March 2020 Austria German
(PDF, 0.4 MB)
LPS BO25323 CLL14 Interim Results March 2020 Germany German
(PDF, 0.4 MB)
LPS BO25323 CLL14 Interim Results March 2020 German Switzerland
(PDF, 0.4 MB)
LPS BO25323 CLL14 Interim Results March 2020 Hungarian
(PDF, 0.3 MB)
LPS BO25323 CLL14 Interim Results March2020 Italy Italian
(PDF, 0.4 MB)
LPS BO25323 CLL14 Interim Results March 2020 Switzerland Italian
(PDF, 0.4 MB)
LPS BO25323 CLL14 Interim Results March 2020 Polish
(PDF, 0.4 MB)
LPS BO25323 CLL14 Interim Results March 2020 Brazil Portuguese
(PDF, 0.4 MB)
LPS BO25323 CLL14 Interim Results March 2020 Romanian
(PDF, 0.4 MB)
LPS BO25323 CLL14 Interim Results March 2020 Estonia Russian
(PDF, 0.4 MB)
LPS BO25323 CLL14 Interim Results March 2020 Russia Russian
(PDF, 0.4 MB)
LPS BO25323 CLL14 Interim Results March 2020 Latin America Spanish
(PDF, 0.3 MB)
LPS BO25323 CLL14 Interim Results March 2020 Spain Spanish
(PDF, 0.4 MB)
LPS BO25323 CLL14 Final Results August 2026 English
(PDF, 0.3 MB)
LPS BO25323 CLL14 Final Results August 2026 Argentina Spanish
(PDF, 0.5 MB)
LPS BO25323 CLL14 Final Results August 2026 Austria German
(PDF, 0.5 MB)
LPS BO25323 CLL14 Final Results August 2026 Brazil Portuguese
(PDF, 0.6 MB)
LPS BO25323 CLL14 Final Results August 2026 Bulgarian
(PDF, 0.5 MB)
LPS BO25323 CLL14 Final Results August 2026 Canada French
(PDF, 0.5 MB)
LPS BO25323 CLL14 Final Results August 2026 Croatian
(PDF, 0.5 MB)
LPS BO25323 CLL14 Final Results August 2026 Danish
(PDF, 0.5 MB)
LPS BO25323 CLL14 Final Results August 2026 Estonia Estonian
(PDF, 0.4 MB)
LPS BO25323 CLL14 Final Results August 2026 Estonia Russian
(PDF, 0.5 MB)
LPS BO25323 CLL14 Final Results August 2026 France French
(PDF, 0.5 MB)
LPS BO25323 CLL14 Final Results August 2026 Germany German
(PDF, 0.5 MB)
LPS BO25323 CLL14 Final Results August 2026 Italy Italian
(PDF, 0.6 MB)
LPS BO25323 CLL14_f Final Results August 2026 Mexico Spanish
(PDF, 0.4 MB)
LPS BO25323 CLL14 Final Results August 2026 Polish
(PDF, 0.5 MB)
LPS BO25323 CLL14 Final Results August 2026 Russia Russian
(PDF, 0.5 MB)
LPS BO25323 CLL14 Final Results August 2026 Spain Spanish
(PDF, 0.4 MB)
LPS BO25323 CLL14 Final Results August2026 Switzerland French
(PDF, 0.5 MB)
LPS BO25323 CLL14 Final Results August 2026 Switzerland German
(PDF, 0.5 MB)
LPS BO25323 CLL14 Final Results August 2026 Switzerland Italian
(PDF, 0.4 MB)
LPS BO25323 CLL14 Final Results August 2026 USA Spanish
(PDF, 0.4 MB)
LPS BO25323 CLL14 Final Results August 2026 Romanian
(PDF, 0.5 MB)
Explore related studies
For the latest version of this information please go to www.forpatients.roche.com